Blanket Purchase Agreement V797D30085-36C25920A0032

Award Date 3/25/20
Last Date to Order 3/24/21
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
Coronavirus COVID-19
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 2 to Biofire Diagnostics LLC, a biotech company specializing in infectious disease diagnostic testing. The BPA, valued at $2,442,440.05, is a single-award contract established against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract...
This Blanket Purchase Agreement (BPA) contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract is for the provision of PCR lab testing kits to support the VA healthcare system, with a total ceiling value of $749,137.80 and a period of performance through September 30, 2024. The contract was...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 (VISN 10) awarded a Blanket Purchase Agreement (BPA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $809,835 single-award BPA, which utilizes Biofire Diagnostics' General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests, will provide reagents to VA facilities in...
This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to Biofire Diagnostics, LLC. The BPA calls for molecular pathogen detection testing services at a cost per test of $1 under the Master GSA Schedule Invitro Diagnostics, Reagents, Test. Specifically, Biofire Diagnostics will provide COVID-19 testing for Veterans in VISN 8 at its location in Emigration Canyon, Utah from June 1, 2020 through...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a blanket purchase agreement to Biofire Diagnostics LLC for molecular pathogen detection services. Biofire will provide products and services to support VHA programs such as COVID-19 testing, diagnostic testing, and infectious disease screening. Performance locations include Utah, Florida, and other states. Estimated values range from $30k to over $1.5M for individual task orders, with...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 19 awarded a Blanket Purchase Agreement (BPA) contract to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company specializing in syndromic infectious disease testing equipment and reagents. The $4.65 million BPA, with a period of performance through September 2026, provides a long-term vehicle for the VA to procure Biofire reagents and extended warranties for maintenance of Biofire diagnostic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a blanket purchase agreement to Biofire Diagnostics, LLC to provide COVID-19 laboratory testing services and associated support. The single award IDV has a potential value of $5.7M and period of performance through September 2025. Task orders issued against the BPA between October 2021 and September 2023 have totaled approximately $3.5M to date for services in Emigration Canyon,...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE MOLECULAR TESTING products and services. The $209,568.78 contract, which has a period of performance through September 30, 2025, is under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. Biomerieux Inc., through its Biomerieux, Inc. division, will supply the VA with its...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company. The BPA, valued at up to $7,000,000, is issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. It allows for streamlined, as-needed procurement of Biofire's advanced...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded two blanket purchase agreement calls to Biofire Diagnostics, LLC. The first BPA call, awarded July 26, 2022, has a value of approximately $644,627.13 to provide laboratory supplies for proprietary equipment through July 25, 2023 in Emigration Canyon, Utah. The second BPA call, awarded July 28, 2021, has a value of approximately $2,692,593.02 to provide the same supplies through July...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests to Biofire Diagnostics, LLC. The BPA has a potential value of $695,000 and aims to procure COVID-19 test kits through March 2021 in response to the Coronavirus pandemic.

A call against the BPA was issued for $167,395.49 to deliver Biofire Torch Systems for molecular diagnostic testing of SARS-CoV-2 in Sheridan, Wyoming by March 2021. The Biofire Torch platform can detect the virus from patient samples to support the VA's testing needs. No set-aside provision was specified. As the largest integrated health care system in the U.S., the VA seeks to efficiently test and treat affected Veterans through this contracting action with Biofire Diagnostics.

Generated 1/4/24, 4:48 PM